27/04/2022 |
Evaluation of Clinical Performance of INFANTIX in a Maternity Hospital |
CNEURO |
Registered |
20/04/2022 |
Jusvinza in rheumatoid arthritis |
CIGB |
Registered |
16/05/2022 |
Effect of dietary fiber consumption on health |
kmunoz |
Registered |
06/12/2022 |
Nasal recombinant human interferon alfa-2b in ARI |
CIGB |
Registered |
20/09/2022 |
NeuroEPO in mild-moderate Alzheimer's disease |
CIM |
Registered |
22/09/2022 |
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
CIM |
Registered |
29/07/2022 |
Nasalferon in ARI |
CIGB |
Registered |
24/04/2023 |
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
CBQ |
Registered |
30/08/2022 |
Sinopharm-SOBERANA COVID-Cienfuegos |
FINLAY |
Registered |
30/01/2023 |
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
DIRECCION DE INVESTIGACION UCE |
Registered |
06/12/2022 |
Prebiotics and probiotics in the treatment of type 2 diabetes |
HHA |
Registered |
06/01/2023 |
IVD in colon cancer |
HHA |
Registered |
16/08/2023 |
Her1 vaccine in metastatic colon and prostate cancer |
CIM |
Registered |
19/05/2023 |
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects |
FINLAY |
Registered |
06/07/2023 |
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock |
CIGB |
Registered |
17/04/2023 |
Dietzia safety study |
HHA |
Registered |
24/04/2023 |
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III |
CIGB |
Registered |
03/08/2023 |
Study on pneunococcal vaccination in the pediatric population from 1 year to 5 years |
FINLAY |
Registered |
21/07/2023 |
Safety of Orally Administered Neutral pH Super Oxidation Electrolyzed Solution |
SSA |
Registered |
07/08/2023 |
Safety evaluation of Bacillus coagulans AO1167 for its use as a probiotic in humans |
HHA |
Registered |